GlassScriptPhysician profile
Alexis Black
NPI 1649943937
$8,050.30
in general payments reported to CMS, 2019-2025
45 companies · $3,017 in 2025
The $3,017 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $221 · 2022: $793 · 2023: $1,816 · 2024: $2,203 · 2025: $3,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,002 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,002.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $939.24 | 2022-2025 | Wegovy, Ozempic |
| Teva Pharmaceuticals USA, INC. | $607.01 | 2023-2025 | Austedo Xr, Austedo Xr |
| Genzyme Corporation | $482.40 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $429.42 | 2023-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $395.84 | 2022-2024 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $384.45 | 2023-2025 | Uptravi, Opsumit |
| Abbott Laboratories | $321.41 | 2023-2025 | Freestyle Libre 3, Diamondback Peripheral, Assurity |
| Neurelis, INC. | $315.18 | 2021-2024 | Valtoco |
| Dexcom, INC. | $285.67 | 2023-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $254.07 | 2022-2025 | |
| Gilead Sciences, INC. | $252.49 | 2024-2025 | Epclusa |
| Abbvie INC. | $248.81 | 2024 | |
| Janssen Biotech, INC. | $223.49 | 2025 | Tremfya |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $198.05 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $193.00 | 2022-2025 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $170.59 | 2023-2024 | Spravato, Xarelto |
| Madrigal Pharmaceuticals | $146.52 | 2025 | Rezdiffra |
| Bayer Healthcare Pharmaceuticals INC. | $139.67 | 2025 | |
| Inari Medical, INC. | $138.49 | 2021 | |
| Organon LLC | $137.77 | 2025 | Vtama |
| Exact Sciences Corporation | $135.53 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Edwards Lifesciences Corporation | $125.01 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2024 | Jardiance |
| Phathom Pharmaceuticals, INC. | $124.99 | 2024 | Voquezna |
| Sanofi Pasteur INC. | $124.97 | 2023 | |
| Xeris Pharmaceuticals, INC. | $121.87 | 2023 | Gvoke Hypopen |
| Idorsia Pharmaceuticals US INC | $120.39 | 2023 | Quviviq |
| Alexion Pharmaceuticals, INC. | $113.71 | 2022 | |
| Ucb, INC. | $110.03 | 2024-2025 | Bimzelx, Cimzia |
| Viiv Healthcare Company | $102.30 | 2025 | Apretude |
| Itamar Medical INC | $98.22 | 2023 | Watchpatone |
| Shockwave Medical, INC | $69.67 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $68.61 | 2024-2025 | |
| Seagen INC. | $61.00 | 2022-2023 | Padcev |
| Amgen INC. | $45.01 | 2022-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $36.57 | 2023 | Wolverine Coronary Cutting Balloon, Synergy |
| Merck Sharp & Dohme LLC | $34.07 | 2023 | Verquvo |
| Becton, Dickinson and Company | $34.00 | 2025 | Introducer Needle |
| Abiomed | $25.06 | 2025 | |
| Iovance Biotherapeutics, INC. | $21.44 | 2025 | Amtagvi |
| Otsuka America Pharmaceutical, INC. | $21.31 | 2024 | Abilify Maintena |
| Lilly USA, LLC | $20.94 | 2024 | Zepbound, Mounjaro |
| Kiniksa Pharmaceuticals International, Plc | $18.72 | 2024 | Arcalyst |
| Cardiovascular Systems INC. | $15.53 | 2022 | |
| Bard Peripheral Vascular, INC. | $12.79 | 2023 | Lifestream |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.